Iovance Biotherapeutics, Inc. (IOVA) Ownership
IOVA ownership summary
as of October 18, 2026- Institutions
- 70.8% of shares outstanding
- Insiders
- 0.35% of shares outstanding
- Shares outstanding
- 453.0M
- Float
- 394.3M shares available to trade
- Short interest
- 15.31% 64.8M shares short
- Days to cover
- 3.69 short interest down 25.6% vs prior month
- Institutions 70.82%
- Insiders 0.35%
- Other investors 28.83%
IOVA top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 8.16% | 37.0M | $503.4M | +5.9M (+18.9%) | June 30, 2026 |
| 2 | Mhr Fund Management Llc | 6.39% | 29.0M | $394.5M | — | June 30, 2026 |
| 3 | State Street Corp | 5.40% | 24.5M | $333.4M | +7.0M (+40.3%) | June 30, 2026 |
| 4 | Two Sigma Investments LLC | 4.20% | 19.0M | $258.9M | +5.3M (+38.9%) | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 4.02% | 18.2M | $247.9M | +1.6M (+9.5%) | June 30, 2026 |
| 6 | Vanguard Portfolio Management, LLC | 3.18% | 14.4M | $196.0M | +2.7M (+23.0%) | June 30, 2026 |
| 7 | Geode Capital Management, LLC | 2.28% | 10.3M | $140.6M | +1.8M (+20.4%) | June 30, 2026 |
| 8 | Millennium Management LLC | 1.88% | 8.5M | $116.1M | −888,373 (−9.4%) | June 30, 2026 |
| 9 | Dimensional Fund Advisors, Inc. | 1.43% | 6.5M | $88.0M | +3.8M (+144.2%) | June 30, 2026 |
| 10 | Palo Alto Investors, LLC | 1.17% | 5.3M | $72.1M | −1.1M (−16.6%) | June 30, 2026 |
| 11 | The Goldman Sachs Group Inc | 1.13% | 5.1M | $69.4M | −3.7M (−41.8%) | June 30, 2026 |
| 12 | Nuveen, LLC | 1.10% | 5.0M | $68.1M | +1.3M (+36.4%) | June 30, 2026 |
| 13 | Bank of America Corp | 1.10% | 5.0M | $68.0M | −3.5M (−41.2%) | June 30, 2026 |
| 14 | Morgan Stanley - Brokerage Accounts | 1.10% | 5.0M | $67.9M | −1.2M (−19.6%) | June 30, 2026 |
| 15 | Jupiter Asset Management Limited | 1.00% | 4.5M | $61.8M | +4.5M (0.0%) | June 30, 2026 |
| 16 | Jane Street Group LLC | 0.97% | 4.4M | $59.8M | +219,967 (+5.3%) | June 30, 2026 |
| 17 | Northern Trust Corp | 0.92% | 4.2M | $56.6M | +1.3M (+44.5%) | June 30, 2026 |
| 18 | AQR Capital Management LLC | 0.85% | 3.9M | $52.7M | +3.2M (+520.0%) | June 30, 2026 |
| 19 | Wells Fargo & Co | 0.72% | 3.2M | $44.2M | +1.2M (+56.7%) | June 30, 2026 |
| 20 | Charles Schwab Investment Management Inc | 0.71% | 3.2M | $43.9M | +435,926 (+15.7%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 14 holders added 40.3M shares and 5 cut 10.3M.
IOVA top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.98% | 13.5M | $184.0M | −24,258 (−0.2%) | August 31, 2026 |
| 2 | State Street® SPDR® S&P® Biotech ETF | 2.50% | 11.3M | $154.2M | −215,550 (−1.9%) | September 30, 2026 |
| 3 | iShares Russell 2000 ETF | 2.27% | 10.3M | $140.2M | −118,592 (−1.1%) | September 30, 2026 |
| 4 | Vanguard Small Cap Index | 1.07% | 4.8M | $66.0M | −32,164 (−0.7%) | September 30, 2026 |
| 5 | Jupiter Merian Glb Eq Abs Rt I USD Acc | 0.96% | 4.4M | $59.5M | +4.4M (0.0%) | June 30, 2026 |
| 6 | Fidelity Small Cap Index | 0.96% | 4.4M | $59.3M | +36,563 (+0.8%) | July 31, 2026 |
| 7 | iShares Russell 2000 Value ETF | 0.82% | 3.7M | $50.8M | +5,656 (+0.2%) | September 30, 2026 |
| 8 | iShares Biotechnology ETF | 0.68% | 3.1M | $41.8M | −23,248 (−0.8%) | September 30, 2026 |
| 9 | Nuveen Quant Small Cap Equity R6 | 0.60% | 2.7M | $36.9M | — | August 31, 2026 |
| 10 | Rhenman Healthcare Equity L/S RC2 SEK | 0.56% | 2.5M | $34.7M | +950,000 (+59.5%) | January 31, 2026 |
| 11 | Vanguard Russell 2000 ETF | 0.51% | 2.3M | $31.5M | +25,867 (+1.1%) | September 30, 2026 |
| 12 | Schwab US Small-Cap ETF™ | 0.46% | 2.1M | $28.2M | +1,395 (+0.1%) | September 30, 2026 |
| 13 | Vanguard Strategic Equity Inv | 0.45% | 2.0M | $27.5M | +926,623 (+84.9%) | June 30, 2026 |
| 14 | Fidelity Extended Market Index | 0.41% | 1.8M | $25.1M | −20,994 (−1.1%) | August 31, 2026 |
| 15 | Vanguard MStar Small Cap Value Index | 0.35% | 1.6M | $21.5M | −1.5M (−49.2%) | September 30, 2026 |
| 16 | Fidelity Enhanced Small Cap Core ETF | 0.33% | 1.5M | $20.3M | +3,126 (+0.2%) | September 30, 2026 |
| 17 | T. Rowe Price Health Sciences | 0.32% | 1.4M | $19.6M | — | September 30, 2026 |
| 18 | Vanguard MStar Small Cap Growth Indx Inv | 0.30% | 1.3M | $18.4M | +1.3M (0.0%) | September 30, 2026 |
| 19 | DFA US Small Cap I | 0.30% | 1.3M | $18.3M | — | August 31, 2026 |
| 20 | C WorldWide Healthcare Select 1A | 0.28% | 1.3M | $17.2M | — | June 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
IOVA insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Raj K Puri | Buy | $1.74 | 5,600 | $9,744 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
IOVA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns IOVA
Institutional investors own 70.8% of Iovance Biotherapeutics's shares and insiders 0.35%. The largest holder is BlackRock Inc with 8.16% of the shares (37.0M), as of June 30, 2026. Among the top 20 institutions, 14 added shares and 5 reduced their stake in the latest filings. Short interest is 15.31% of the float, or 3.69 days of average trading volume. The share count rose 980.1% since 2014.
Related: IOVA analyst forecast, IOVA key metrics. See the IOVA stock overview for the latest quote and news.
IOVA ownership FAQ
Who owns the most Iovance Biotherapeutics stock?
The largest shareholders of Iovance Biotherapeutics are BlackRock Inc (8.16%), Mhr Fund Management Llc (6.39%), State Street Corp (5.40%), Two Sigma Investments LLC (4.20%), Vanguard Capital Management, LLC (4.02%).
What percentage of Iovance Biotherapeutics is owned by institutions?
Institutions hold 70.8% of Iovance Biotherapeutics's shares outstanding; insiders hold 0.35%.
Which funds own Iovance Biotherapeutics?
The largest fund holders of Iovance Biotherapeutics are Vanguard MStar Total Stk Mkt Idx Invest (2.98%), State Street® SPDR® S&P® Biotech ETF (2.50%), iShares Russell 2000 ETF (2.27%), Vanguard Small Cap Index (1.07%), Jupiter Merian Glb Eq Abs Rt I USD Acc (0.96%).
What is Iovance Biotherapeutics's short interest?
64.8M shares of Iovance Biotherapeutics were sold short, 15.31% of the float; at the average daily volume it would take 3.69 days to cover.
Are insiders buying or selling Iovance Biotherapeutics?
Of the latest 1 reported insider transactions in Iovance Biotherapeutics (since May 23, 2025), 1 were purchases and 0 were sales.
How many shares of Iovance Biotherapeutics are outstanding?
Iovance Biotherapeutics has 453.0M shares outstanding, of which 394.3M are in the public float.